Fibrocell Science is an autologous cell and gene therapy company focused on translating personalized biologics for diseases affecting the skin and connective tissue. Co.'s development programs consist of the following: FCX-007, which is a genetically-modified autologous fibroblast that encodes the gene for type VII collagen for localized treatment of recessive dystrophic epidermolysis bullosa; FCX-013, which is an autologous fibroblast genetically-modified using lentivirus and encoded for matrix metalloproteinase 1; and Gene Therapy Research Program, which is in the research phase and is focused on the treatment of arthritis and related conditions. We show 8 historical shares outstanding datapoints in our FCSC shares outstanding history coverage, used to compute FCSC market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing FCSC market cap history over the course of time is important for investors
interested in comparing FCSC's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of FCSC versus a peer is one thing; comparing
FCSC market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like FCSC can fluctuate over the course of history.
With this page we aim to empower investors researching FCSC by allowing them to research the FCSC market cap history. |
Free FCSC Email Alerts:
Video: The Importance of Market Cap
